Avatar photo

Prof. Jérôme Boursier

Prof. Jerome Boursier (MD, PhD) is an esteemed hepatologist and researcher from Angers University
  • Articles: 2
Videos & Slides: 2

Non-Invasive Evaluation Of NAFLD Severity Slide

Liver fibrosis should be evaluated in all patients diagnosed with NAFLD. Non-invasive tests such as blood tests and liver elastography are now available for an accurate diagnosis of advanced liver fibrosis in NAFLD. The sequential use of non-invasive tests define patient pathways from primary care/diabetology clinics to liver specialists. Therefore, awareness about NAFLD and the use of such non-invasive tests should be reinforced to improve the case findings of patients with advanced liver fibrosis.

Read MoreNon-Invasive Evaluation Of NAFLD Severity Slide

Non-Invasive Evaluation of NAFLD Severity

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are a leading cause of liver diseases worldwide, including hepatocellular carcinoma (HCC). In this review on non-invasive evaluation, Prof. Jérôme Boursier, France, presents a meta analysis focusing on the identification of patients with high risk profile and in need of specific management. Dr. Boursier reviews the two major families of non-invasive tests and discusses the sequential use of tests recommended in the EASL guidelines 2021.

Read MoreNon-Invasive Evaluation of NAFLD Severity